Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The first two cantharidin analogues displaying PP1 selectivity.

Adam McCluskey1, Mirella A Keane, Cecilia C Walkom

  • 1Medicinal Chemistry Group, School of Biological and Chemical Sciences, The University of Newcastle, University Drive, Callaghan, Newcastle, NSW 2308, Australia. amcclusk@mail.newcastle.edu.au

Bioorganic & Medicinal Chemistry Letters
|January 30, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Twenty years of quinazolines as tubulin polymerisation inhibitors.

RSC medicinal chemistry·2026
Same author

Psychosocial aspects of RUNX1-familial platelet disorder in adolescents and young adults: "The fear of knowing it could happen sometime down the road".

Journal of genetic counseling·2026
Same author

Sulfonadyn Compounds: A Class of Aryl Sulfonamides That Inhibit Dynamin GTPase and Clathrin-Mediated Endocytosis and Are Antiepileptic in Animal Models.

ACS chemical biology·2026
Same author

How we Investigate Bone Marrow Failure Syndromes in Pediatric Patients.

Pediatric hematology and oncology·2026
Same author

Restricting glycine uptake with bitopertin improves erythropoiesis in preclinical models of Diamond-Blackfan anemia.

Blood. Red cells & iron·2026
Same author

<i>In vitro</i> activity of robenidine analogue NCL195 against methicillin-resistant <i>Staphylococcus pseudintermedius</i>.

Microbiology spectrum·2026

New cantharidin analogues synthesized via high pressure Diels-Alder reactions show selective inhibition of protein phosphatase 1 (PP1) over protein phosphatase 2A (PP2A). These compounds offer potential for targeted therapeutic development.

Area of Science:

  • Organic Chemistry
  • Medicinal Chemistry
  • Biochemistry

Background:

  • Protein phosphatases, specifically protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), are crucial enzymes involved in cellular regulation.
  • Dysregulation of protein phosphatase activity is implicated in various diseases, making them attractive therapeutic targets.

Purpose of the Study:

  • To synthesize novel cantharidin analogues using high-pressure Diels-Alder reactions.
  • To evaluate the synthesized compounds for their selectivity and inhibitory activity against PP1 and PP2A.

Main Methods:

  • High-pressure Diels-Alder reactions between furan and dimethylmaleate, and thiophene and maleimide.
  • Biochemical assays to determine PP1 and PP2A inhibitory activity and selectivity.

Related Experiment Videos

Main Results:

  • Two cantharidin analogues, compounds 3 and 6, were successfully synthesized.
  • Both compounds demonstrated significant selectivity for PP1 over PP2A (40-fold and 30-fold, respectively).
  • Compound 6 exhibited moderate PP1 inhibitory activity with an IC50 of 12.5 microM, while compound 3 had an IC50 of 50 microM.

Conclusions:

  • The synthesized cantharidin analogues possess promising PP1 selectivity.
  • The structural modifications, particularly the ester groups, play a role in the observed selectivity.
  • These compounds represent potential lead structures for developing targeted PP1 inhibitors.